Press release
Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum in the Global Pulmonary Drug Delivery Devices Market
Pulmonary Drug Delivery Devices Market
Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025, with a compound annual growth rate (CAGR) of 6.6%. This growth in the historical period can be linked to factors such as the rising incidence of respiratory conditions like chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis, an increasing aging population globally, heightened awareness about respiratory health importance, growth of healthcare spending in developing economies, and the rising preference for homecare settings for respiratory treatment.
Pulmonary Drug Delivery Devices Market Size Forecast: What's the Projected Valuation by 2029?
Expectations are high for significant expansion in the pulmonary drug delivery devices market in the coming years. The projected market size is estimated to reach $68.18 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. This anticipated growth during the forecast period can be tied to factors such as increasing demand for personalized and precision respiratory care, the spread of home healthcare services and remote patient monitoring, heightened investment in research and development, and an amplified focus on preventive healthcare and early intervention strategies. Key trends likely to emerge in this time include technological advancements, a transition towards value-based care models and patient-centric methodologies, the incorporation of telehealth and remote monitoring facilities into respiratory treatment platforms, the engagement of wearables and mobile apps for managing respiratory conditions independently, and the implementation of 3D printing and digital manufacturing methods.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pulmonary-drug-delivery-devices-global-market-report
What Are the Drivers Transforming the Pulmonary Drug Delivery Devices Market?
The growing incidents of respiratory ailments are predicted to boost the expansion of the pulmonary drug delivery devices market. Respiratory ailments encompass diseases or conditions impacting the lungs and airways, thereby affecting human breathing. Factors such as heightened levels of air pollution, surging smoking habits, urban growth, climate alteration, and the graying population contribute to an increased prevalence of these disorders. Pulmonary drug delivery devices are crucial in treating such conditions as they allow for the direct delivery of medication to the lungs. For example, the Centers for Disease Control And Prevention (CDC), a US-based national public health institute, stated in May 2024 that the prevalence of current asthma among adults aged 18 and above rose from 8.0% in 2021 to 8.7% in 2022. Therefore, the increasing incidents of respiratory ailments are projected to drive the expansion of the pulmonary drug delivery devices market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
Which Fast-Growing Trends Are Poised to Disrupt the Pulmonary Drug Delivery Devices Market?
Leading businesses in the pulmonary drug delivery devices market are driving innovation by developing ground-breaking products like small-volume nebulizers to improve patient care with advanced functionalities. A small-volume nebulizer (SVN) is a specialized equipment utilized to administer aerosolized mist of liquid medicine to individuals suffering from respiratory issues such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. For instance, in May 2024, the U.S. based healthcare company, Medline Industries LP, introduced the Hudson RCI TurboMist small-volume nebulizer to the market. This revolutionary device can deliver medication treatments in a shortened time frame, as brief as three minutes. This impressive nebulizer is capable of delivering 2.5 times more medication per minute when compared to its standard counterparts, reducing treatment times by about 70%. This substantial rise in medicine delivery markedly lowers therapy session duration, offering advantages to healthcare providers by maximizing patient throughput and enhancing patient experience by cutting short the therapy session time.
Which Segments in the Pulmonary Drug Delivery Devices Market Offer the Most Profit Potential?
The pulmonary drug delivery devices market covered in this report is segmented -
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp
Which Firms Dominate the Pulmonary Drug Delivery Devices Market by Market Share and Revenue in 2025?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson and Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Masimo Corporation, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc., Nidek Medical Products Inc.
Which Regions Offer the Highest Growth Potential in the Pulmonary Drug Delivery Devices Market?
North America was the largest region in the pulmonary drug delivery devices market in 2024. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15907
This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum in the Global Pulmonary Drug Delivery Devices Market here
News-ID: 4217471 • Views: …
More Releases from The Business Research Company
Dental Anesthesia Market Report Evaluates Growth Drivers, Challenges And Market …
The dental anesthesia sector is poised for significant growth as advancements in technology and evolving patient needs drive demand. With innovations improving safety and effectiveness, the market is expected to witness notable expansion over the coming years. Let's explore the current market size, key players, emerging trends, and segmentation that define the dental anesthesia industry today.
Projected Market Size and Growth Outlook for the Dental Anesthesia Industry
The dental anesthesia…
Demulcent Eye Drops Market Report Provides Insights Into Market Evolution And Gr …
The demulcent eye drops market is positioned for notable expansion in the coming years, driven by rising awareness about eye health and advances in product formulations. As consumers increasingly seek effective solutions for dry eye and related conditions, this market is expected to experience robust growth along several key dimensions.
Projected Market Value and Growth Outlook for Demulcent Eye Drops
By 2030, the demulcent eye drops market size is forecasted…
Deep Learning In Drug Discovery And Diagnostics Market Research Explores Growth …
The deep learning sector within drug discovery and diagnostics is rapidly evolving, driven by innovations that promise to transform healthcare. As artificial intelligence technologies become increasingly integrated into life sciences, the market is set to experience remarkable growth. Below, we explore the current market valuation, key players, emerging trends, and detailed segmentation to provide a comprehensive overview of this dynamic field.
Market Valuation Outlook for Deep Learning in Drug Discovery and…
Decentralized Trial Wearable Market Analysis Highlights Growth To $6.18 Billion …
The decentralized trial wearable industry is set to undergo remarkable expansion over the coming years, driven by technological advancements and evolving clinical research needs. This sector is increasingly attracting attention due to its potential to transform how clinical trials are conducted by enhancing remote patient monitoring and data accuracy. Let's explore the market's current outlook, key players, emerging trends, and the segments shaping its future trajectory.
Forecasted Market Value and Growth…
More Releases for Pulmonary
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers…
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027.
Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion.
Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC…
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of…
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs
Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated…
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments…
Latest Report: Global Pulmonary Hypertension Market
MarketResearchReports.Biz presents this most up-to-date research on "Pulmonary Hypertension-Pipeline Insights, 2017"
DelveInsights, Pulmonary Hypertension-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Pulmonary Hypertension. The DelveInsightsReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations,…
